Current UK NSC recommendations > Hypertrophic Cardiomyopathy

The UK NSC recommendation on Hypertrophic Cardiomyopathy (HCM) screening in teenagers (archived)

This recommendation is no longer active

Date of deactivation 7 August 2015
Reason for deactivation This policy has since been superseded by Sudden Cardiac Death in 2015.
Recommendation Systematic population screening programme not recommended
Key downloads

Screening should not be offered. Pre-participation screening of athletes for HCM or other causes of sudden cardiac death should not be instituted at present.


Why is screening not recommended by UK NSC?

Evidence suggested that the available test for Hypertrophic Cardiomyopathy was not yet accurate enough to correctly identify conditions which could lead to Sudden Cardiac Death without also identifying people with
healthy hearts. There was a considerable risk that tests would be positive when the person had no illness (these are called false positive results) which could result in healthy people worrying unnecessarily that they they have a heart problem. This could cause them to change their behaviour and even avoid exercise and activity beneficial to their overall health.

More about Hypertrophic Cardiomyopathy

HCM is an inherited condition which, in the majority of affected people, does not limit the quality and duration of life. It is a disorder of the heart consisting of excessive growth of the muscle, which may begin before birth when the fetal heart is developing. The natural history is characterised by slow progression of symptoms but a significant incidence of sudden death.

» Read more about hypertrophic cardiomyopathy on the Contact a Family website

Related documents

icon Hypertrophic Cardiomyopathy Policy review (PDF document, 74KB, 03/12/10)
icon Notes of the UK NSC Stakeholder Meeting on Screening for Sudden Cardiac Death in Young People (PDF document, 306KB, 03/12/10)

More options

Go to top